Availability of naloxone in Canadian pharmacies:a population-based survey.

about

Availability of naloxone in Canadian pharmacies:a population-based survey.

Item

http://www.wikidata.org/entity/Q47161749

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Availability of naloxone in Canadian pharmacies:a population-based survey.

@en

Availability of naloxone in Canadian pharmacies:a population-based survey.

@nl

type

Item

label

Availability of naloxone in Canadian pharmacies:a population-based survey.

@en

Availability of naloxone in Canadian pharmacies:a population-based survey.

@nl

prefLabel

Availability of naloxone in Canadian pharmacies:a population-based survey.

@en

Availability of naloxone in Canadian pharmacies:a population-based survey.

@nl

P1476

Availability of naloxone in Canadian pharmacies:a population-based survey.

@en

P2093

Alex M Cressman

http://www.w3.org/2001/XMLSchema#string

David N Juurlink

http://www.w3.org/2001/XMLSchema#string

Graham Mazereeuw

http://www.w3.org/2001/XMLSchema#string

Qi Guan

http://www.w3.org/2001/XMLSchema#string

Tara Gomes

http://www.w3.org/2001/XMLSchema#string

Wenting Jia

http://www.w3.org/2001/XMLSchema#string

P2860

Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis

Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009

High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

A review: Fentanyl and non-pharmaceutical fentanyls.

Comparative Usability Study of a Novel Auto-Injector and an Intranasal System for Naloxone Delivery.

Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.

Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist.

Opioid dose and drug-related mortality in patients with nonmalignant pain.

P304

E779-E784

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.9778/CMAJO.20170123

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29117991

http://www.w3.org/2001/XMLSchema#string

P932

5741422

http://www.w3.org/2001/XMLSchema#string